$0.00
(0.00%
) Quote details
USD
( 0.00%
At Close (As of Jan 1, 1970)
$217.41M
Market Cap
-
P/E Ratio
-4.76
EPS
$20.77
52 Week High
$4.63
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company located in Norwood, Massachusetts, specializing in the development of innovative therapies that target the endocannabinoid system to tackle pressing unmet medical needs in autoimmunity, fibrosis, and oncology. The company boasts a diverse and promising pipeline aimed at enhancing treatment modalities for chronic diseases, with the potential to reshape patient care paradigms. With its distinct approach to cannabinoid-based therapies, Corbus is strategically poised to attract institutional investors eager to engage with pioneering advancements in the healthcare sector.
YYAI
BYND
SCNX
F
CGBS
VHAI
RGTI
AIRE
RIG
TSLA
VTYX
NOK
QBTS
NVDA
T
INTC
MSAI
ADAP
AAL
BITF
AREB
IONQ
DNN
PLUG
SMCI
TLRY
VZ
GRAB
SOFI
JOBY
RF
CAN
QS
AMD
VLY
PLTR
LAES
RXRX
PFE
BTBT
AMC
UUUU
CIFR
MARA
WBD
DVLT
HPE
NIO
IREN
KMI
NVTS
PBR
SOUN
LUV
RR
SCWO
SNAP
BAC
APLD
DNUT
HOOD
LUMN
VALE
NCLH
ERIC
CLSK
KDLY
SMR
YYAI
BYND
SCNX
F
CGBS
VHAI
RGTI
AIRE
RIG
TSLA
VTYX
NOK
QBTS
NVDA
T
INTC
MSAI
ADAP
AAL
BITF
AREB
IONQ
DNN
PLUG
SMCI
TLRY
VZ
GRAB
SOFI
JOBY
RF
CAN
QS
AMD
VLY
PLTR
LAES
RXRX
PFE
BTBT
AMC
UUUU
CIFR
MARA
WBD
DVLT
HPE
NIO
IREN
KMI
NVTS
PBR
SOUN
LUV
RR
SCWO
SNAP
BAC
APLD
DNUT
HOOD
LUMN
VALE
NCLH
ERIC
CLSK
KDLY
SMR